K. Kemper, M. Köhne, M. van der Kroef, K. Nuermberger, M. Russier, G. Zom, Anna-Lena Krause, P. de Goeje, F. Gieseke, A. Gorlani, A. Muik, L. Guelen, D. Satijn, S. Fellermeier-Kopf, T. Ahmadi, Ö. Türeci, E. Breij, U. Şahin
{"title":"148P HexaBody-OX40:一种不依赖 Fcγ 受体交联的新型 OX40 靶向抗体,具有体外激动活性和体内抗肿瘤活性","authors":"K. Kemper, M. Köhne, M. van der Kroef, K. Nuermberger, M. Russier, G. Zom, Anna-Lena Krause, P. de Goeje, F. Gieseke, A. Gorlani, A. Muik, L. Guelen, D. Satijn, S. Fellermeier-Kopf, T. Ahmadi, Ö. Türeci, E. Breij, U. Şahin","doi":"10.1016/j.iotech.2023.100620","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 31","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"148P HexaBody-OX40: A novel Fcγ receptor crosslinking-independent OX40-targeting antibody, exhibits agonistic activity in vitro and antitumor activity in vivo\",\"authors\":\"K. Kemper, M. Köhne, M. van der Kroef, K. Nuermberger, M. Russier, G. Zom, Anna-Lena Krause, P. de Goeje, F. Gieseke, A. Gorlani, A. Muik, L. Guelen, D. Satijn, S. Fellermeier-Kopf, T. Ahmadi, Ö. Türeci, E. Breij, U. Şahin\",\"doi\":\"10.1016/j.iotech.2023.100620\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":192507,\"journal\":{\"name\":\"Immuno-Oncology and Technology\",\"volume\":\" 31\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-Oncology and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.iotech.2023.100620\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100620","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
148P HexaBody-OX40: A novel Fcγ receptor crosslinking-independent OX40-targeting antibody, exhibits agonistic activity in vitro and antitumor activity in vivo